XML 21 R55.htm IDEA: XBRL DOCUMENT v2.4.0.6
Enterprise-wide Sales Information (Details) (USD $)
12 Months Ended
Jul. 31, 2012
Jul. 31, 2011
Jul. 31, 2010
Revenue from External Customer [Line Items]      
Net sales $ 60,014,000 $ 55,657,000 $ 52,010,000
Revenues from External Customers [Line Items]      
Net sales 60,014,000 55,657,000 52,010,000
Recognition of Deferred Revenue 1,500,000 1,000,000 0
Domestic [Member]
     
Revenue from External Customer [Line Items]      
Net sales 44,047,000 38,997,000 35,417,000
Revenues from External Customers [Line Items]      
Net sales 44,047,000 38,997,000 35,417,000
International [Member]
     
Revenue from External Customer [Line Items]      
Net sales 15,967,000 16,660,000 16,593,000
Revenues from External Customers [Line Items]      
Net sales 15,967,000 16,660,000 16,593,000
Ophthalmic [Member]
     
Revenue from External Customer [Line Items]      
Net sales 35,240,000 34,547,000 31,689,000
Revenues from External Customers [Line Items]      
Net sales 35,240,000 34,547,000 31,689,000
OEM [Member]
     
Revenue from External Customer [Line Items]      
Net sales 23,973,000 [1] 19,456,000 [1] 12,082,000 [1]
Revenues from External Customers [Line Items]      
Net sales 23,973,000 [1] 19,456,000 [1] 12,082,000 [1]
Other [Member]
     
Revenue from External Customer [Line Items]      
Net sales 801,000 [2] 1,654,000 [2] 8,239,000 [2]
Revenues from External Customers [Line Items]      
Net sales $ 801,000 [2] $ 1,654,000 [2] $ 8,239,000 [2]
[1] Revenues from OEM represent sales of electrosurgery generators, disposable bipolar forceps and related accessories, and royalties from Codman, multi-channel generators, disposable ultrasonic tips and related accessories to Stryker and certain laser probes to Iridex Corporation. In addition, recognition of deferred revenues of $1.5 million and $1.0 million from Codman and Alcon, respectively, are included in this category for the periods ending July 31, 2012 and 2011. There was no recognition of deferred revenue recorded in fiscal 2010.
[2] Revenues from Other represent direct neurosurgery revenues and other miscellaneous revenues.